Seminars in Thrombosis and Hemostasis

Erscheinungsweise:
8 pro Jahr

ISSN:
0094-6176

Sprache:
Englisch


Sofort lieferbar, Lieferzeit des ersten Heftes 5-8 Werktage nach Erscheinen des Heftes

Personal print subscription 2019, incl. online ToolTip Personal subscription orders must include the recipient´s name and private address, and be paid by private funds. Only qualified professionals and students are eligible for individual subscriptions.
Handling charges will be added.

EUR 450,00

Special introductory rate, personal subscription, incl. online ToolTip This offer is valid for new individual subscribers only and is limited to the first year of the subscription. Orders must include the recipient’s name and private address, and be paid by private funds. Shipping charges will be added.

EUR 360,00

Inkl. gesetzl. MwSt.

Versandkosten pro Jahr:
Inland: EUR 92,00
Europa: EUR 92,00
Übersee: EUR 92,00

Hinweis::
Alle genannten Preise gelten für persönlich/private Abonnements. Informationen zu institutionellen Abonnements finden Sie unter www.thieme-connect.de/thieme-ejournals

In den Warenkorb

Produktblatt drucken Weiterempfehlen

Abonnementkonditionen
Das Abonnement läuft nach Bestelleingang mindestens ein Jahr und kann anschließend jederzeit mit dreimonatiger Frist zum Jahresende gekündigt werden. Der laufende Jahrgang wird anteilig berechnet. Ausführliche Information finden Sie in unseren Verbraucherinformation,
Nutzungs- und Bestellbedingungen

Beschreibung

Seminars in Thrombosis and Hemostasis is a topic driven review journal that focuses on all issues relating to hemostatic and thrombotic disorders. As one of the premiere review journals in the field, Seminars in Thrombosis and Hemostasis serves as a comprehensive forum for important advances in clinical and laboratory diagnosis and therapeutic interventions.

Seminars offers an informed perspective on today's pivotal issues, including hemophilia A & B, thrombophilia, gene therapy, venous and arterial thrombosis, von Willebrand disease, vascular disorders and thromboembolic diseases. Attention is also given to the latest developments in pharmaceutical drugs along with treatment and current management techniques. The journal also frequently publishes sponsored supplements to further highlight emerging trends in the field.